Cite
HARVARD Citation
Khan, M. et al. (2019). CNS atypical T-cell lymphoproliferative disease following treatment with alemtuzumab. Neurology. 9 (3), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Khan, M. et al. (2019). CNS atypical T-cell lymphoproliferative disease following treatment with alemtuzumab. Neurology. 9 (3), p. . [Online].